HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BCMV protocol

chemotherapy protocol consisting of above cpds; used in treatment of head & neck squamous cell, nonseminomatous germ cell & nasopharyngeal cancers

Also Known As:

PVB+M protocol; PVB-M protocol; UICC-2 protocol

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1190486
- Drug Therapy: 300623
  - Combination Drug Therapy: 12155
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - BCMV protocol: 1
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - BCMV protocol: 1
- Clinical Protocols
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - BCMV protocol: 1
Carbohydrates: 22516
- Glycoconjugates: 1370
  - Glycopeptides: 1966
    - Bleomycin: 10030
      - BCMV protocol: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 84029
  - Glycopeptides: 1966
    - Bleomycin: 10030
      - BCMV protocol: 1
Inorganic Chemicals: 9
Heterocyclic Compounds: 207
- Alkaloids: 5592
  - Indole Alkaloids: 206
    - Secologanin Tryptamine Alkaloids: 84
      - Vinca Alkaloids: 466
        Vinblastine: 3383
        BCMV protocol: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds

Related Diseases

1.	Nasopharyngeal Carcinoma 05/01/1997 - "Three patients who received chemotherapy according to a modified UICC-2 protocol for nasopharyngeal carcinoma and 50 to 54 Gy to the primary site had only mild early toxicity and mild late effects of treatment. "

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)